Need Help?
Copied to clipboard!

Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)

Publications Citations
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
J Clin Oncol 42: 2024 1229-1240
115
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Blood 144: 2024 771-783
16
Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Blood Cancer Discov 6: 2025 450-463
3
Genomic features do not account for differences in multiple myeloma risk by ancestry.
Blood Cancer Discov 7: 2026 742-758
0